| Ranked [title] Word list | Historiographs | Help Glossary HistCite Guide About |
| Nodes: 1870, Authors: 3375, Journals: 582, Outer References: 65037, Words: 4301, Tags: 3
Yearly output | Document Type | Language | Institution | Institution with Subdivision | Country |
| View: Overview | Sorted by GCS. |
| # | Word | Pubs | TLCS | TGCS |
|---|---|---|---|---|
| 801 | POLYMERASE-ALPHA | 1 | 1 | 103 |
| 802 | SPECTRIN | 5 | 3 | 103 |
| 803 | STATES | 4 | 15 | 103 |
| 804 | ZINC | 1 | 2 | 103 |
| 805 | ACETATE-GROWN | 1 | 0 | 102 |
| 806 | AGGREGATE | 1 | 0 | 102 |
| 807 | CARBON-MONOXIDE | 1 | 0 | 102 |
| 808 | CLOSTRIDIUM-THERMOCELLUM | 1 | 0 | 102 |
| 809 | CORRINOID | 1 | 0 | 102 |
| 810 | COTYLEDONARY | 1 | 0 | 102 |
| 811 | CRYSTALLINE | 1 | 0 | 102 |
| 812 | DEGRADE | 1 | 0 | 102 |
| 813 | DEHYDROGENASE-ACTIVITY | 1 | 0 | 102 |
| 814 | INDEXES | 4 | 13 | 102 |
| 815 | METHANOSARCINA-THERMOPHILA | 1 | 0 | 102 |
| 816 | MONOCLONAL-ANTIBODIES | 4 | 0 | 102 |
| 817 | NICKEL | 1 | 0 | 102 |
| 818 | PISUM-SATIVUM | 1 | 0 | 102 |
| 819 | STORAGE | 1 | 0 | 102 |
| 820 | SUBUNITS | 7 | 2 | 102 |
| 821 | ACETONE | 4 | 44 | 101 |
| 822 | BIOCHEMICAL-CHARACTERIZATION | 2 | 0 | 101 |
| 823 | CURRENT | 5 | 5 | 101 |
| 824 | PLASMA.I | 1 | 24 | 101 |
| 825 | REGION | 2 | 2 | 101 |
| 826 | ACIDIC | 4 | 13 | 100 |
| 827 | CROSSLINKING | 2 | 95 | 100 |
| 828 | FAILURE | 2 | 4 | 100 |
| 829 | UNUSUAL | 7 | 6 | 100 |
| 830 | ADSORBENT | 2 | 0 | 99 |
| # | Word | Pubs | TLCS | TGCS |
| 831 | ANHYDRASES | 2 | 4 | 99 |
| 832 | CACL | 1 | 4 | 99 |
| 833 | INTESTINAL | 6 | 0 | 99 |
| 834 | SILICA | 6 | 34 | 99 |
| 835 | SKIN | 4 | 18 | 99 |
| 836 | BROWN | 3 | 2 | 98 |
| 837 | ERYTHROCYTE-MEMBRANE | 4 | 6 | 98 |
| 838 | FLUORESCENCE | 5 | 17 | 98 |
| 839 | METHODOLOGICAL | 2 | 9 | 98 |
| 840 | AGGREGATING | 3 | 8 | 97 |
| 841 | BIOLOGICALLY | 3 | 45 | 97 |
| 842 | CARCINOSARCOMA | 1 | 0 | 97 |
| 843 | CELLULOLYTIC | 2 | 8 | 97 |
| 844 | FUTURE | 4 | 1 | 97 |
| 845 | HAEMATOLOGY | 1 | 81 | 97 |
| 846 | NOVIKOFF | 1 | 0 | 97 |
| 847 | REFERENCE | 6 | 6 | 97 |
| 848 | RESPIRATION | 2 | 1 | 97 |
| 849 | WALKER | 1 | 0 | 97 |
| 850 | HEPARIN-DERIVED | 1 | 1 | 96 |
| 851 | MULTIFUNCTIONAL | 2 | 39 | 96 |
| 852 | OLIGOSACCHARIDES | 1 | 1 | 96 |
| 853 | ASPIRIN | 4 | 7 | 95 |
| 854 | PANCREATITIS | 1 | 3 | 95 |
| 855 | SECONDARY | 2 | 24 | 95 |
| 856 | SIGNIFICANCE | 6 | 12 | 95 |
| 857 | WEIGHTS | 2 | 25 | 95 |
| 858 | ASHKENAZI | 1 | 5 | 94 |
| 859 | ATPASE | 4 | 7 | 94 |
| 860 | BETA-GLUCOSIDASES | 2 | 6 | 94 |
| # | Word | Pubs | TLCS | TGCS |
| 861 | CONCLUDED | 2 | 13 | 94 |
| 862 | DEGREE | 1 | 94 | 94 |
| 863 | IMPROVEMENT | 1 | 94 | 94 |
| 864 | JEWS | 1 | 5 | 94 |
| 865 | KINASE | 6 | 2 | 94 |
| 866 | PATIENT | 6 | 11 | 94 |
| 867 | SULFATE | 6 | 17 | 94 |
| 868 | ERYTHROCYTES | 6 | 6 | 93 |
| 869 | ISOZYMES | 4 | 0 | 93 |
| 870 | MITOCHONDRIAL | 3 | 0 | 93 |
| 871 | WILLEBRANDS | 5 | 4 | 93 |
| 872 | DIETARY-FAT | 2 | 1 | 92 |
| 873 | INDUCES | 1 | 1 | 92 |
| 874 | KININOGEN-I | 3 | 24 | 92 |
| 875 | LOBSTER | 3 | 1 | 92 |
| 876 | ORIGIN | 4 | 2 | 92 |
| 877 | PLASMA-FREE | 1 | 1 | 92 |
| 878 | RECOGNITION | 3 | 3 | 92 |
| 879 | RIBONUCLEIC | 2 | 9 | 92 |
| 880 | CAUSING | 1 | 1 | 91 |
| 881 | EUBACTERIUM-ACIDAMINOPHILUM | 4 | 10 | 91 |
| 882 | FEMALE | 4 | 24 | 91 |
| 883 | G4-GLOBULIN | 1 | 1 | 91 |
| 884 | GAMMA | 1 | 1 | 91 |
| 885 | GLYCINE | 5 | 10 | 91 |
| 886 | PROLONGED | 3 | 6 | 91 |
| 887 | PUBLICATIONS | 3 | 10 | 91 |
| 888 | SEPARATIONS | 9 | 20 | 91 |
| 889 | STIMULATION | 3 | 7 | 91 |
| 890 | ACCUMULATION | 3 | 0 | 90 |
| # | Word | Pubs | TLCS | TGCS |
| 891 | CATABOLISM | 3 | 3 | 90 |
| 892 | NATIVE | 11 | 7 | 90 |
| 893 | PERFUSED | 2 | 1 | 90 |
| 894 | REPRODUCIBILITY | 2 | 2 | 90 |
| 895 | ALDEHYDE | 3 | 0 | 89 |
| 896 | ARTIFICIALLY | 1 | 12 | 89 |
| 897 | CONDITIONS | 6 | 14 | 89 |
| 898 | DEPLETED | 1 | 12 | 89 |
| 899 | FUNCTIONAL-PROPERTIES | 2 | 6 | 89 |
| 900 | STABILIZATION | 2 | 0 | 89 |
| 901 | AHF | 3 | 11 | 88 |
| 902 | CHALLENGES | 1 | 1 | 88 |
| 903 | GAMMA-CHAIN | 2 | 5 | 88 |
| 904 | POST-TRANSLATIONAL | 1 | 1 | 88 |
| 905 | PROJECTS | 1 | 1 | 88 |
| 906 | SLABS | 8 | 14 | 88 |
| 907 | VECTOR | 1 | 1 | 88 |
| 908 | WOMEN | 5 | 4 | 88 |
| 909 | EXON | 1 | 2 | 87 |
| 910 | FLANKING | 1 | 2 | 87 |
| 911 | NORWAY | 2 | 2 | 87 |
| 912 | ASSESSMENT | 11 | 5 | 86 |
| 913 | GLUTAMINE-SYNTHETASE | 2 | 1 | 86 |
| 914 | HEMOPHILIA-A | 3 | 15 | 86 |
| 915 | HEREDITY | 2 | 8 | 86 |
| 916 | OBTAINED | 4 | 3 | 86 |
| 917 | SEPARATING | 1 | 6 | 86 |
| 918 | ALPHA-2-MACROGLOBULIN | 1 | 6 | 85 |
| 919 | ALPHA-2-MACROGLOBULIN-KALLIKREIN | 1 | 6 | 85 |
| 920 | HAEMOSTATIC | 3 | 0 | 85 |
| # | Word | Pubs | TLCS | TGCS |
| 921 | L-HOMOCYSTINE | 1 | 4 | 85 |
| 922 | NERVE | 2 | 0 | 85 |
| 923 | NEUTRAL | 2 | 1 | 85 |
| 924 | PSEUDOMONAS-PUTIDA | 2 | 2 | 85 |
| 925 | SPECTRUM | 2 | 1 | 85 |
| 926 | UTILIZING | 1 | 6 | 85 |
| 927 | ALTERATION | 1 | 24 | 84 |
| 928 | AMINO-ACID-SEQUENCE | 1 | 0 | 84 |
| 929 | DEPLETION | 2 | 13 | 84 |
| 930 | IGG | 4 | 0 | 84 |
| 931 | SEMINAL | 1 | 0 | 84 |
| 932 | THROMBOCYTOPENIA | 4 | 6 | 84 |
| 933 | CELLULAR | 3 | 0 | 83 |
| 934 | ERYTHROCYTE-MEMBRANES | 3 | 9 | 83 |
| 935 | HEAVY | 1 | 6 | 83 |
| 936 | LIGHT-CHAINS | 1 | 6 | 83 |
| 937 | MATRIX | 6 | 2 | 83 |
| 938 | TUMOR | 2 | 0 | 83 |
| 939 | BIOSPECIFIC | 1 | 0 | 82 |
| 940 | CHLOROPLAST | 4 | 0 | 82 |
| 941 | CLOT | 4 | 7 | 82 |
| 942 | HYPERSENSITIVITY | 2 | 1 | 82 |
| 943 | IMPORTANCES | 1 | 7 | 82 |
| 944 | INITIATING | 2 | 7 | 82 |
| 945 | PATHOLOGICAL | 2 | 34 | 82 |
| 946 | POLAR | 1 | 7 | 82 |
| 947 | SYNTHETASE | 1 | 0 | 82 |
| 948 | THYMIDYLATE | 1 | 0 | 82 |
| 949 | VESICLES | 2 | 15 | 82 |
| 950 | DIATHESIS | 4 | 10 | 81 |
| # | Word | Pubs | TLCS | TGCS |
| 951 | MEDIATED | 1 | 32 | 81 |
| 952 | PRODUCTS | 5 | 1 | 81 |
| 953 | SYNOVIAL | 3 | 18 | 81 |
| 954 | CONSTITUENTS | 2 | 1 | 80 |
| 955 | EMBOLISM | 1 | 2 | 80 |
| 956 | GLYCOPROTEINS | 3 | 3 | 80 |
| 957 | KALLIKREIN-LIKE | 4 | 19 | 80 |
| 958 | PARTICULATE | 2 | 4 | 80 |
| 959 | RATTLESNAKE | 3 | 1 | 80 |
| 960 | AGGREGATES | 3 | 15 | 79 |
| 961 | ANTIGEN-ANTIBODY | 2 | 15 | 79 |
| 962 | CONTENT | 9 | 8 | 79 |
| 963 | MICE | 7 | 6 | 79 |
| 964 | NONTHROMBOGENIC | 1 | 0 | 79 |
| 965 | REGIONS | 1 | 21 | 79 |
| 966 | SEPARATE | 2 | 21 | 79 |
| 967 | SITE | 4 | 1 | 79 |
| 968 | TYPHOID-FEVER | 1 | 8 | 79 |
| 969 | SEED | 4 | 0 | 78 |
| 970 | THERAPEUTIC | 3 | 1 | 78 |
| 971 | ACID-INDUCED | 2 | 10 | 77 |
| 972 | CAPILLARIES | 1 | 9 | 77 |
| 973 | HUMAN-SERA | 1 | 0 | 77 |
| 974 | IMPORTANCE | 3 | 6 | 77 |
| 975 | MACROMOLECULAR-SOLUBLE | 1 | 4 | 77 |
| 976 | MICRO-ELECTROPHORESIS | 1 | 9 | 77 |
| 977 | NATURAL | 4 | 7 | 77 |
| 978 | RECOGNIZED | 1 | 0 | 77 |
| 979 | STAGES | 1 | 77 | 77 |
| 980 | TOXOPLASMA-GONDII | 1 | 0 | 77 |
| # | Word | Pubs | TLCS | TGCS |
| 981 | HUMAN-ERYTHROCYTE | 4 | 3 | 76 |
| 982 | IMMUNOGLOBULINS | 5 | 6 | 76 |
| 983 | MAP | 1 | 3 | 76 |
| 984 | MOLECULAR-SIZE | 3 | 21 | 76 |
| 985 | MUSCLE | 4 | 3 | 76 |
| 986 | OXIDE | 2 | 0 | 76 |
| 987 | SALT | 2 | 2 | 76 |
| 988 | SIALOGLYCOPROTEIN | 1 | 33 | 76 |
| 989 | SKELETAL-MUSCLE | 3 | 0 | 76 |
| 990 | VON | 6 | 15 | 76 |
| 991 | FIBRINOGENS | 2 | 0 | 75 |
| 992 | LIPIDS | 5 | 0 | 75 |
| 993 | PROBLEM | 2 | 1 | 75 |
| 994 | SUGGESTED | 2 | 1 | 75 |
| 995 | THROMBI | 3 | 4 | 75 |
| 996 | DODECYL | 3 | 11 | 74 |
| 997 | FACTOR-VIII-C | 2 | 3 | 74 |
| 998 | PHOSPHOLIPIDS | 3 | 3 | 74 |
| 999 | PROCESSING | 4 | 39 | 74 |
| 1000 | SOURCES | 4 | 8 | 74 |